Nichi Iko Pharmaceutical Co Ltd - Company & Market Research Reports

Nich-Iko is a pharmaceutical company that manufactures, sells and distributes products for circulatory, digestive, respiratory, central and peripheral nervous systems and others. It was founded in 1965 and it is headquartered in Tokyo. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005.

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • 85 Pages
From
Japan Generics Drug Market Outlook 2020 - Product Thumbnail Image

Japan Generics Drug Market Outlook 2020

  • Report
  • 66 Pages
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2018 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 413 Pages
From
The Overview of Japanese Generic Drug Market - Product Thumbnail Image

The Overview of Japanese Generic Drug Market

  • Report
  • 20 Pages
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 482 Pages
From
The Overveiw of Japanese Generic Drug Market Ver2016 - Product Thumbnail Image

The Overveiw of Japanese Generic Drug Market Ver2016

  • Report
  • 20 Pages
Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 408 Pages
From
Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline Review, H2 2018 - Product Thumbnail Image

Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 61 Pages
From
Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook - Product Thumbnail Image

Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

  • Report
  • 70 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Competitor Analysis: Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors - Product Thumbnail Image

Competitor Analysis: Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors

  • Report
  • 58 Pages
From
Psoriasis - Pipeline Review, H2 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 726 Pages
From
Psoriasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 709 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update

  • Report
  • 124 Pages
From
Psoriatic Arthritis - Pipeline Review, H1 2018 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 241 Pages
From
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 201 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2018 - Product Thumbnail Image

Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 66 Pages
From
Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors - Product Thumbnail Image

Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors

  • Report
  • 67 Pages
From
Japan Biosimilars - The Start of Authorized Biosimilar Era? - Product Thumbnail Image

Japan Biosimilars - The Start of Authorized Biosimilar Era?

  • Report
  • 128 Pages
From
Loading Indicator
adroll